<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C81341B0-BEB1-46A2-B6CA-9EED6B183AE0"><gtr:id>C81341B0-BEB1-46A2-B6CA-9EED6B183AE0</gtr:id><gtr:name>University of Bari Aldo Moro</gtr:name><gtr:address><gtr:line1>Piazza Umberto I, 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/39387A8B-DE6F-4056-865E-3013C290FC4E"><gtr:id>39387A8B-DE6F-4056-865E-3013C290FC4E</gtr:id><gtr:name>MRC Human Nutrition Research Group</gtr:name><gtr:address><gtr:line1>MRC Human Nutrition Research Group</gtr:line1><gtr:line2>Medical Research Council (HQ)</gtr:line2><gtr:line3>Elsie Widdowson laboratory Fulbourn Road</gtr:line3><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/39387A8B-DE6F-4056-865E-3013C290FC4E"><gtr:id>39387A8B-DE6F-4056-865E-3013C290FC4E</gtr:id><gtr:name>MRC Human Nutrition Research Group</gtr:name><gtr:address><gtr:line1>MRC Human Nutrition Research Group</gtr:line1><gtr:line2>Medical Research Council (HQ)</gtr:line2><gtr:line3>Elsie Widdowson laboratory Fulbourn Road</gtr:line3><gtr:postCode>CB1 9NL</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598"><gtr:id>798EE1A4-3D20-4DF0-A6CD-E6F6C2E22598</gtr:id><gtr:name>Agilent Technologies UK Ltd</gtr:name><gtr:address><gtr:line1>610 Wharfedale Road</gtr:line1><gtr:line2>IQ Winnersh</gtr:line2><gtr:postCode>RG41 5TP</gtr:postCode><gtr:region>South East</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE5027A2-9A29-4322-AB89-41E0AF3BC9FF"><gtr:id>BE5027A2-9A29-4322-AB89-41E0AF3BC9FF</gtr:id><gtr:name>MedImmune</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C81341B0-BEB1-46A2-B6CA-9EED6B183AE0"><gtr:id>C81341B0-BEB1-46A2-B6CA-9EED6B183AE0</gtr:id><gtr:name>University of Bari Aldo Moro</gtr:name><gtr:address><gtr:line1>Piazza Umberto I, 1</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/7B37377E-AAF0-4C32-BA3D-0395632DCBB7"><gtr:id>7B37377E-AAF0-4C32-BA3D-0395632DCBB7</gtr:id><gtr:firstName>Julian</gtr:firstName><gtr:otherNames>Leether</gtr:otherNames><gtr:surname>Griffin</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/60F94A2A-4B83-4F9C-8F07-A4260DCE0450"><gtr:id>60F94A2A-4B83-4F9C-8F07-A4260DCE0450</gtr:id><gtr:firstName>Stephen</gtr:firstName><gtr:surname>O'Rahilly</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/161DE809-8AE4-4978-9F68-F106C8C63ED0"><gtr:id>161DE809-8AE4-4978-9F68-F106C8C63ED0</gtr:id><gtr:firstName>Nicholas</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Wareham</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/7902F95B-B478-40FF-A142-55E496884A55"><gtr:id>7902F95B-B478-40FF-A142-55E496884A55</gtr:id><gtr:firstName>Ann</gtr:firstName><gtr:surname>Prentice</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/5FA70E6B-48E9-4FBC-A8A5-93AD364FA95B"><gtr:id>5FA70E6B-48E9-4FBC-A8A5-93AD364FA95B</gtr:id><gtr:firstName>Leslie</gtr:firstName><gtr:otherNames>John Charles</gtr:otherNames><gtr:surname>Bluck</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_13030"><gtr:id>70BDCCFC-E3DF-4083-87F3-51F2995E708E</gtr:id><gtr:title>Proposal to enhance linked research in human fat metabolism &amp;amp; pathophysiology between MRC HNR, MRC MDU and MRC EU</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_13030</gtr:grantReference><gtr:abstractText>According to statistics reported by Diabetes UK in 2010, since 1996 the number of people diagnosed with diabetes has increased from 1.4 million to 2.6 million, and is set to rise to four million people by 2025. The majority of these cases are associated with type 2 diabetes (T2DM), with the increased prevalence arising from an increasingly aged population and the rise in overweight and obese people. However, there is increasing realisation that T2DM is not a homogenous disease and can arise from a number of different pathways related to diet, life style and genetic influences. Because of this there is increasing realisation that ?one size? does not fit all in terms of treatment. Indeed, certain individuals may particularly benefit from targeted diet and drug interventions as part of an approach referred to as ?personalised medicine.? This initiative sets out to understand the underlying pathways that influence why an individual might develop T2DM using analytical chemistry approaches to define patient groups according to their metabolism. We plan to use metabolic changes, termed biomarkers, to better identify patient groups who would benefit from particular treatments. This personalised medicine approach should improve health of individuals as well as providing a significant financial saving to the healthcare system.</gtr:abstractText><gtr:technicalSummary>With the increasing burden that type 2 diabetes (T2DM) and aspects of the metabolic syndrome place on the National Health Service and the wider economy there is a drive to stratify patients into treatment groups to maximise response to interventions to prevent insulin resistance (IR) be it through diet, physical activity or drug intervention. By its very definition the metabolic syndrome is a cluster of disorders. It is also now a widely held view that T2DM is a heterogeneous collection of pathological disorders all sharing the common outcome of hyperglycaemia. There is a growing realisation that effective treatments for complex disorders such as T2DM and dyslipidaemia will require ?deep phenotyping? of the individuals to allow the implementation of personalised medicine and nutritional interventions.
This drive towards personalised medicine and nutrition has been impaired by the lack of personalised diagnosis. The limited development and validation of relatively few biomarkers hampers real stratification of individuals, and the majority of the current markers used for the diagnosis of the metabolic syndrome and T2DM are associated with the effects of the clinical endpoint or the clinical endpoint itself. One reason for this lack of translation is the difficulties of performing controlled intervention studies in humans to validate molecular mechanisms of a potential diagnostic biomarker alongside the biomarker discovery studies. As part of the MRC/Wellcome Trust funded Cambridge Initiative in Obesity and Metabolic Disease we are applying human intervention studies in order to better understand the mechanistic basis underpinning potential biomarkers developed within the groups led by Griffin and Bluck as well as collaborators at MRC Units and the University of Cambridge that make up the rest of the Initiative. To achieve this we are applying our world-class specialisms in high resolution mass spectrometry of lipids and stable isotope analysis for kinetic measurement of substrate flux to measure biomarkers and flux changes in well controlled human physiological interventions.
The current focus is in the understanding of the contribution of de novo lipogenesis (DNL) to fatty liver disease in those that are either considered healthy or have mild IR. From our previous work in lipodystrophic patients we know that triglycerides associated with DNL are increased in blood plasma and the activity of the pathway is raised as measured by stable isotope studies. We are currently conducting studies to directly measure DNL alongside blood plasma triglycerides using a combination of stable isotope techniques and high resolution mass spectrometry in different patient groups and at risk individuals.</gtr:technicalSummary><gtr:fund><gtr:end>2016-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-05-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>904743</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Antonio Moschetta. Lipidomics and Bile Acid profiling in liver disease</gtr:description><gtr:id>6A3DD605-A086-41FD-B19A-6A3EB6040A57</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>58be7aaacac3f6.11382535-1</gtr:outcomeId><gtr:partnerContribution>Provided animal models for the collaboration.</gtr:partnerContribution><gtr:piContribution>Collaborating on understanding the role bile acids play in fatty liver disease</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Collaboration with the Department of Physiology Development &amp;amp; Neuroscience, University of Cambridge (HNR project 6503)</gtr:description><gtr:id>2532F457-99DC-4672-BF18-5AA799FA9BBF</gtr:id><gtr:impact>TBC</gtr:impact><gtr:outcomeId>546361be1a7810.88092486-1</gtr:outcomeId><gtr:partnerContribution>Andrew Murray's group in the Department of Physiology Development and Neuroscience, UCam oversaw the study</gtr:partnerContribution><gtr:piContribution>Liver metabolome (HNR project 6503), liver, plasma, adipose and intestine samples were collected for a mouse strain and gender comparison of the lipid and low molecular weight species of the liver metabolome (many thanks to JLG, Xinzhu Wang, LR and Frank Sanders for the sample collection.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Bari</gtr:collaboratingOrganisation><gtr:country>Italy, Italian Republic</gtr:country><gtr:description>Lipidomics in a population eating the Mediterranean diet</gtr:description><gtr:id>8A887B0F-BAA5-4E79-90CE-96B444F0ACC0</gtr:id><gtr:impact>None to date - currently processing data.</gtr:impact><gtr:outcomeId>56d81520eec7c5.32689833-1</gtr:outcomeId><gtr:partnerContribution>Providing blood plasma samples from an on-going Italian cohort</gtr:partnerContribution><gtr:piContribution>FS and MVa have established a collaboration with the University of Bari, Italy, for a project that will translate our murine studies into human research of the link between de novo lipogensis and fatty liver disease. The MTA is now in place and the University of Bari received the final approval from the ethics committee for sending the serum samples. .</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Institute of Health and Society</gtr:department><gtr:description>Collaborations with Newcastle University on fatty liver disease</gtr:description><gtr:id>DA7F8833-906B-49F5-8AC4-D517D008AD1A</gtr:id><gtr:impact>Still in progress</gtr:impact><gtr:outcomeId>58be7bf24cf170.42749853-1</gtr:outcomeId><gtr:partnerContribution>Fiona Oakley. Metabolic control of liver regeneration and hepatocellular carcinogenesis 
Q Anstee. SNPs in NASH affecting lipidome</gtr:partnerContribution><gtr:piContribution>Fiona Oakley. Metabolic control of liver regeneration and hepatocellular carcinogenesis 
Q Anstee. SNPs in NASH affecting lipidome</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2017-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration with Medimmune</gtr:description><gtr:id>55E8EF3F-6A4D-454E-BB1C-6F064ABF1AB5</gtr:id><gtr:impact>None as yet</gtr:impact><gtr:outcomeId>5461da8be99624.84792317-1</gtr:outcomeId><gtr:partnerContribution>See above!</gtr:partnerContribution><gtr:piContribution>We have initated a collaboration with medimmune in terms of making our expertise and facilities in metabolomics and lipidomics available to the cardiovascular and metabolic diseases group and in return we have been offered access to their high throughput cell culture facilities, we are discussing CASE studentships and also access to previously generated mouse models of obesity and fatty liver disease.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MedImmune</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Cambridge Metabolism Network</gtr:description><gtr:id>DEBD417B-2C9F-41A3-8C01-C5F736AE5541</gtr:id><gtr:impact>Got a CASE studentship in a multi-disciplinary research area.</gtr:impact><gtr:outcomeId>56d81ce3a1b8a6.24246837-1</gtr:outcomeId><gtr:partnerContribution>To my group they have provided a PhD studentship.</gtr:partnerContribution><gtr:piContribution>I am a member of the organising committee for the Cambridge Metabolomics Network. This has included two meetings on metabolism. The events have been sponsored by AZ, MedImmune and Novartis and contact with AZ led to a CASE pHD studentship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Cambridge Metabolism Network</gtr:description><gtr:id>5BD439E5-C8F6-4FD4-A832-61C512FF486D</gtr:id><gtr:impact>Got a CASE studentship in a multi-disciplinary research area.</gtr:impact><gtr:outcomeId>56d81ce3a1b8a6.24246837-2</gtr:outcomeId><gtr:partnerContribution>To my group they have provided a PhD studentship.</gtr:partnerContribution><gtr:piContribution>I am a member of the organising committee for the Cambridge Metabolomics Network. This has included two meetings on metabolism. The events have been sponsored by AZ, MedImmune and Novartis and contact with AZ led to a CASE pHD studentship.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Agilent Technologies</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Thought Leader Award from Agilent</gtr:description><gtr:id>712090F2-57E0-49ED-B0D0-A4BCB10FBB5E</gtr:id><gtr:impact>The collaboration starts in december 2014</gtr:impact><gtr:outcomeId>5461dbea4e1886.99008579-1</gtr:outcomeId><gtr:partnerContribution>see above.</gtr:partnerContribution><gtr:piContribution>Agilent have awarded a Thought Leader award to the head of group. This consists of a brand new ion mobility mass spectrometry plus substantial funds for research to develop this new piece of equipment. In turn we will develop new mass spectrometry tools based around ion mobility for lipid detection.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Oxford</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Collaboration with Cardiovascular medicine, University of Oxford</gtr:description><gtr:id>C13BB7E3-CD69-4669-9B45-419011737F9D</gtr:id><gtr:impact>None to date</gtr:impact><gtr:outcomeId>ctCbFce8BGj-1</gtr:outcomeId><gtr:partnerContribution>We ghave acquired pilot data for grant applications and written grant proposals</gtr:partnerContribution><gtr:piContribution>We are collaborating with Cardiovascular medicine at Oxford to understand the role metabolism plays in hypertrophic cardiomyopathy (HCM). The focus of this work is a translational medicine study of HCM. Our role is to help understand the metabolic changes that are associated with HCM, and in particular the switch from fat metabolism towards carbohydrates (fetal reprogramming).</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Sugar, Fat and the Daily Mail Headlines</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>9FF60D19-E97A-4460-BB57-0601F179770F</gtr:id><gtr:impact>JLG spoke at the 'Skeptics in the Pub' event on 26th May. The video is on YouTube should anyone want to view it!</gtr:impact><gtr:outcomeId>56d8576b8b49d5.72654736</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Metabolomics Workshop at the 20th International Symposium on Microsomes and drug oxidations, stuttgart, germany</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>4A1B371E-BC00-4825-805A-D5D40FF9F798</gtr:id><gtr:impact>academics said they would incorporate metabolomics into their future experiments

See above</gtr:impact><gtr:outcomeId>5461e5a32d2e87.69919748</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>French Embassy Seed meeting</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>BCAAEF2F-7665-4AF8-A8AC-3A55612B773E</gtr:id><gtr:impact>JLG, LR, AA and ZA were invited to the French Embassy to discuss collaborations with colleagues from INRA on metabolomics. This was following a successful application to the French government to fund the meeting by JLG and his counterparts in France.</gtr:impact><gtr:outcomeId>56d981973f3ce1.49481057</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Work experience for two school boys</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>556A4C03-6C6B-4399-9EB3-1F370E0655A7</gtr:id><gtr:impact>Work experience for two school boys: two school boys spent a week in my lab following members around to get some experience of what its like being a scientist.</gtr:impact><gtr:outcomeId>58be9ca3c4fbb4.99465167</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Discussion with Trust me I'm a doctor</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>3E74A7A9-6D5F-4E80-890C-ED33E5DFF8BE</gtr:id><gtr:impact>I advised on a program on energy balance and dieting pills.

Still waiting for the program to air!</gtr:impact><gtr:outcomeId>5461e6fb7a9a77.00213230</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Week cambridge 2016</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FCF7D953-1A9D-411F-85F8-0AE43042DCEC</gtr:id><gtr:impact>: volunteering on 13th March 2016 Cambridge science festival HNR stand: Blood, Fat &amp;amp; the Future</gtr:impact><gtr:outcomeId>58be907dd3b644.52931237</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>2nd Metabolomics Sardinian Scientific School</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>9A2BB48C-AB2A-44DE-837F-D3FD8DBEA9E3</gtr:id><gtr:impact>2nd Metabolomics Sardinian Scientific School was aimed at post-grad students new to the field of metabolomics. We gave seminars and workshops in various tools and techniques in metabolomics.</gtr:impact><gtr:outcomeId>58be91ffd0e376.17281807</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>BBC filming as part of a news report on fat metabolism</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>19943D51-6761-4E31-A721-2BF2CDFD4354</gtr:id><gtr:impact>With MRC Epidemiology we took part in a documentary by the BBC on fat intake. This has led to a number of other media contacts since then.</gtr:impact><gtr:outcomeId>56d8184f23c2a7.38352670</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hosted a visit from Singaporean students</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>759AAE22-67D4-463D-B94B-CA23F94D6870</gtr:id><gtr:impact>We hosted a visit from 6th form Singaporean students interested in applying to Cambridge as undergraduates in science related areas.

They gave me a box of chocolates!</gtr:impact><gtr:outcomeId>pgJCs9prsnn</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Talk on metabolomics at Bedford School</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7F5073C9-CF2D-4C0A-A6A3-0212A5F82B93</gtr:id><gtr:impact>Gave a talk on metabolomics and systems biology to the biology club at Bedford school.</gtr:impact><gtr:outcomeId>56d829169367c8.11537766</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Debating matters - regional final judge</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>974245B2-AA27-4154-BA99-D1F2E3461CB2</gtr:id><gtr:impact>We encouraged students to both debate and think about applying to the University of Cambridge

see above</gtr:impact><gtr:outcomeId>5461e4b6057018.14149414</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Science Week 2017</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>8D2FE5E1-0706-4827-B971-2EC674CAF9C0</gtr:id><gtr:impact>took part in Cambridge Science week and put on a display on personalised medicine and health using advanced biochemical techniques.</gtr:impact><gtr:outcomeId>58c6c9ae213365.21891236</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Contact with the BBC about  a scientific program on diet and food</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>807165D9-37E1-4A38-BF97-6C8D2D8E512F</gtr:id><gtr:impact>CW contacted by Milla Harrison from the BBC doing another Horizon programme - The Biology and Environmental factors behind Obesity. Wanted some advice on genes and genotyping.</gtr:impact><gtr:outcomeId>56dac3325f4682.40934805</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>How the fat flies - Science Week</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>78ACD77B-5F4D-42F3-A203-615F522791E7</gtr:id><gtr:impact>The University of Cambridge Science Festival took place on Saturday 14th and Sunday 15th March. My group had a stand at the Corn Exchange. The stand was split into two, with one half focusing on nutrition and the other on mass spectrometry.</gtr:impact><gtr:outcomeId>56d819d070a8a9.38969733</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Poster presentation at Experimental Biology 2015</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>2BFF6BB8-2AA8-4395-AE29-C24B69F1D134</gtr:id><gtr:impact>One of the PhD students attended Experimental Biology and presented a poster entitled &amp;quot;Effects of green tea and coffee polyphenols on cardiometabolic function in women with Polycystic Ovary Syndrome.&amp;quot; Experimental Biology Boston, USA, 28 March-1 April 2015.</gtr:impact><gtr:outcomeId>56d8223dc1f830.96850998</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>100000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>MedImmune Cambridge</gtr:department><gtr:description>Medimmune industrial studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>MedImmune</gtr:fundingOrg><gtr:id>6DEFEA1D-6A27-4318-9B47-C5F9DB2CDD6D</gtr:id><gtr:outcomeId>58beba775feb94.63297316</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>40000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Astra Zeneca CASE studentship</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>AstraZeneca</gtr:fundingOrg><gtr:id>A611ADBA-9BD0-48FA-9C4B-F2804E4667EF</gtr:id><gtr:outcomeId>58beaca44e25d0.84768316</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>High-throughput &amp;quot;omic&amp;quot; science and imaging call</gtr:description><gtr:end>2014-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>EDFB2395-E972-492F-97B8-E88A217EB16B</gtr:id><gtr:outcomeId>QvtHpyVAvEp</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>BHF Intermediate fellowship for KT</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>British Heart Foundation (BHF)</gtr:fundingOrg><gtr:id>78C8C057-0B79-4A8A-B4E8-E073CB9E97C1</gtr:id><gtr:outcomeId>58c6c6b86c0f76.83569107</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>3000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Amegen Summer studentship - Xavier Fernandez</gtr:description><gtr:end>2015-08-02</gtr:end><gtr:fundingOrg>Amgen Inc</gtr:fundingOrg><gtr:id>CCC0751B-27C2-47F8-82CD-C86DF0115C73</gtr:id><gtr:outcomeId>56d97ea22699a6.29604304</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>65000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust and GSK studentship in translational medicine</gtr:description><gtr:end>2016-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7DF40C0F-219F-4752-B89B-89E3A8785690</gtr:id><gtr:outcomeId>ir6iEYAjpAK</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>124000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Technology Development Grant, MetaboFlow - the development of standardised workflows for processing metabolomics data to aid reproducible data sharing and big data initiatives</gtr:description><gtr:end>2019-11-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>202952/B/16/Z</gtr:fundingRef><gtr:id>3A04E209-811D-447F-9EBC-9358E7A6157B</gtr:id><gtr:outcomeId>58c6c5f430db06.11331108</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>417000</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK-Astra Zeneca partnership awards</gtr:description><gtr:end>2020-03-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:id>4F501897-88F1-4ACD-B8CB-9356EE1638CE</gtr:id><gtr:outcomeId>58c6cb9b7e9075.35425051</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2017-04-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>SACN advisory committee on dietary fats</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>CF3F3632-60ED-4D1E-8394-CC7A3250AC9F</gtr:id><gtr:outcomeId>56dac24a0bd645.44993539</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A42822FA-E248-4928-B869-3E15934A3676</gtr:id><gtr:title>Metabolomics applied to diabetes-lessons from human population studies.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe5a9be79f8adb71f25d7e98091a0aa"><gtr:id>0fe5a9be79f8adb71f25d7e98091a0aa</gtr:id><gtr:otherNames>Liggi S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a616ed3a50da1.14540118</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>68C85F56-DF3C-4A7D-8346-3FDA71D762C7</gtr:id><gtr:title>Association between sucrose intake and risk of overweight and obesity in a prospective sub-cohort of the European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk).</gtr:title><gtr:parentPublicationTitle>Public health nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/304e66d8922856234eb585ca601d6e5c"><gtr:id>304e66d8922856234eb585ca601d6e5c</gtr:id><gtr:otherNames>Kuhnle GG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1368-9800</gtr:issn><gtr:outcomeId>56bb67e80b8359.95981421</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23F5A112-3999-4C25-B919-44BC8F603960</gtr:id><gtr:title>Adipose tissue fatty acid chain length and mono-unsaturation increases with obesity and insulin resistance.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21cb25ff8772b4c914687a805b1d4c64"><gtr:id>21cb25ff8772b4c914687a805b1d4c64</gtr:id><gtr:otherNames>Yew Tan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56bb5ecbc0e064.89752787</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCCBAFD7-8E60-4C44-BE6C-DDC1832E04E7</gtr:id><gtr:title>Controlling overservicing by physicians: review of office practices in Manitoba.</gtr:title><gtr:parentPublicationTitle>CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3209d16da685ee3fdbcf2f51ce9a05fd"><gtr:id>3209d16da685ee3fdbcf2f51ce9a05fd</gtr:id><gtr:otherNames>Wahn M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>1992-01-01</gtr:date><gtr:issn>0820-3946</gtr:issn><gtr:outcomeId>5675eba468ab9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC7261A2-D91F-4AE4-B543-1A298C0C024F</gtr:id><gtr:title>Brown Adipose Tissue Thermogenic Capacity Is Regulated by Elovl6.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5b0fe1561e92f157420919eb81c6a910"><gtr:id>5b0fe1561e92f157420919eb81c6a910</gtr:id><gtr:otherNames>Tan CY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56bb67e5619e62.67929974</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>29646280-43DF-4A82-A10A-0B13D5F188C8</gtr:id><gtr:title>The translation of lipid profiles to nutritional biomarkers in the study of infant metabolism.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4c5bb2295df1ba4ff1ccbe4d58a364"><gtr:id>5a4c5bb2295df1ba4ff1ccbe4d58a364</gtr:id><gtr:otherNames>Acharjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>58bd343cc679e7.03228931</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5841A610-EFD3-4DDB-B52A-EE1BA49A7EEB</gtr:id><gtr:title>Altered colonic mucosal Polyunsaturated Fatty Acid (PUFA) derived lipid mediators in ulcerative colitis: new insight into relationship with disease activity and pathophysiology.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7a65143bcd0487f501fb7eca36c8622f"><gtr:id>7a65143bcd0487f501fb7eca36c8622f</gtr:id><gtr:otherNames>Masoodi M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fa8973cb27.20279622</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A88C2898-12FC-48D9-A241-DE897AA8CA84</gtr:id><gtr:title>Genetic Predisposition to an Impaired Metabolism of the Branched-Chain Amino Acids and Risk of Type 2 Diabetes: A Mendelian Randomisation Analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590c8a9618b273cc7c1e0848dd49db27"><gtr:id>590c8a9618b273cc7c1e0848dd49db27</gtr:id><gtr:otherNames>Lotta LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>58bd343da4b849.62330961</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1B35F6E6-8D72-4BFA-8BBF-FF1C3FAE7445</gtr:id><gtr:title>Methods of Adipose Tissue Biology: Methods of Adipose Tissue Biology: Part B</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/22d38b79efe9178f2b9cd9e0a50000fe"><gtr:id>22d38b79efe9178f2b9cd9e0a50000fe</gtr:id><gtr:otherNames>MacDougald, Ormond</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>9780128002803</gtr:isbn><gtr:outcomeId>i-5635886542.1599583bb54cb8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CFF2E304-EBA0-4F18-B21D-7A4E0F835382</gtr:id><gtr:title>Polyphenol administration impairs T-cell proliferation by imprinting a distinct dendritic cell maturational profile.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6859aa1b165d23fd5fb2d0648e5e4cb4"><gtr:id>6859aa1b165d23fd5fb2d0648e5e4cb4</gtr:id><gtr:otherNames>Delvecchio FR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>585d3190ed78e9.49965908</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D34178E6-9B4F-4045-88E7-D2CBC74DCE84</gtr:id><gtr:title>Integrative miRNA and whole-genome analyses of epicardial adipose tissue in patients with coronary atherosclerosis.</gtr:title><gtr:parentPublicationTitle>Cardiovascular research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe0043d25a0888851cac9f3a9f58eb4"><gtr:id>7fe0043d25a0888851cac9f3a9f58eb4</gtr:id><gtr:otherNames>Vacca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0008-6363</gtr:issn><gtr:outcomeId>585d54ee76fd91.55719655</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>807D5EEA-7393-4ED4-967A-EC3208FF853E</gtr:id><gtr:title>PPAR-pan activation induces hepatic oxidative stress and lipidomic remodelling.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>56bb5ecc443a80.79856525</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0069988-70AC-4F22-83E0-4C8EA76FCA78</gtr:id><gtr:title>Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome.</gtr:title><gtr:parentPublicationTitle>The lancet. Diabetes &amp; endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2213-8587</gtr:issn><gtr:outcomeId>5461fb534dfd27.50920451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F7F8DB79-32D3-46F4-A053-89C07EB57CC1</gtr:id><gtr:title>Clustering nuclear receptors in liver regeneration identifies candidate modulators of hepatocyte proliferation and hepatocarcinoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7fe0043d25a0888851cac9f3a9f58eb4"><gtr:id>7fe0043d25a0888851cac9f3a9f58eb4</gtr:id><gtr:otherNames>Vacca M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5461fb5372f343.09753179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9CD9631-C24F-4B33-BC7C-7F41E1ABDCBF</gtr:id><gtr:title>An extracellular siderophore is required to maintain the mutualistic interaction of Epichlo&amp;euml; festucae with Lolium perenne.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/593547173e2ff230fa8be5a1acd971c6"><gtr:id>593547173e2ff230fa8be5a1acd971c6</gtr:id><gtr:otherNames>Johnson LJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5461fa891cd471.04070316</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94051BBF-D564-4382-A342-64AE68D979BE</gtr:id><gtr:title>Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e137cbde914442352a009c77419799ba"><gtr:id>e137cbde914442352a009c77419799ba</gtr:id><gtr:otherNames>Virtue S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>56bb67e7a96589.82505349</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2071AE0B-936F-443F-9C1F-59355E3BA535</gtr:id><gtr:title>Antioxidants and HNE in redox homeostasis.</gtr:title><gtr:parentPublicationTitle>Free radical biology &amp; medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5642aa2b1d5777a7f41482b60783ed82"><gtr:id>5642aa2b1d5777a7f41482b60783ed82</gtr:id><gtr:otherNames>Luczaj W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0891-5849</gtr:issn><gtr:outcomeId>585d6b01b0ad55.35757089</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8007D86F-82C5-49C6-8B3D-FFEC964FCED1</gtr:id><gtr:title>Association of Plasma Phospholipid n-3 and n-6 Polyunsaturated Fatty Acids with Type 2 Diabetes: The EPIC-InterAct Case-Cohort Study.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d49fb8098ab21616c9235687213475f"><gtr:id>5d49fb8098ab21616c9235687213475f</gtr:id><gtr:otherNames>Forouhi NG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>585d6c1a8ed4c0.35045756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>910019C6-E1F0-4EF6-A033-A6D85ED28F74</gtr:id><gtr:title>Genes and miRNA expression signatures in peripheral blood mononuclear cells in healthy subjects and patients with metabolic syndrome after acute intake of extra virgin olive oil.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/00b43d909c5d39d98458ec4bba40bf04"><gtr:id>00b43d909c5d39d98458ec4bba40bf04</gtr:id><gtr:otherNames>D'Amore S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>58be78b86f3c28.56553836</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E60E083B-FB63-4A41-BEDE-5FC3C011A4C9</gtr:id><gtr:title>Hematopoietic IKBKE limits the chronicity of inflammasome priming and metaflammation.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d6013e7c1934b6d55026ed02e21ab0c8"><gtr:id>d6013e7c1934b6d55026ed02e21ab0c8</gtr:id><gtr:otherNames>Patel MN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>56bb67e8467268.42426177</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1ABC57C-0003-4D34-957F-91FEF1AC210F</gtr:id><gtr:title>Short-term benefits of an unrestricted-calorie traditional Mediterranean diet, modified with a reduced consumption of carbohydrates at evening, in overweight-obese patients.</gtr:title><gtr:parentPublicationTitle>International journal of food sciences and nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/de4edba587b5a18635cfa6c3585275cb"><gtr:id>de4edba587b5a18635cfa6c3585275cb</gtr:id><gtr:otherNames>Salvia R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0963-7486</gtr:issn><gtr:outcomeId>58be78b838c544.04763131</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F770C97B-EF7B-4BC6-A23A-6C76CC17958C</gtr:id><gtr:title>Blood triacylglycerols: a lipidomic window on diet and disease.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d0e3ad7533d1f938a8e188b5620f00a"><gtr:id>4d0e3ad7533d1f938a8e188b5620f00a</gtr:id><gtr:otherNames>Sanders F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>585d510c08eb10.54438350</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>71E88120-4796-4590-AB6A-2482001E1CB8</gtr:id><gtr:title>Integration of metabolomics, lipidomics and clinical data using a machine learning method.</gtr:title><gtr:parentPublicationTitle>BMC bioinformatics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5a4c5bb2295df1ba4ff1ccbe4d58a364"><gtr:id>5a4c5bb2295df1ba4ff1ccbe4d58a364</gtr:id><gtr:otherNames>Acharjee A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2105</gtr:issn><gtr:outcomeId>58bd343d1d3e49.97725497</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BEADC664-969F-4528-8408-47499C052ED8</gtr:id><gtr:title>Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers.</gtr:title><gtr:parentPublicationTitle>Chest</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/567a6df44fe9ec1809d4232be794446a"><gtr:id>567a6df44fe9ec1809d4232be794446a</gtr:id><gtr:otherNames>Yang L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0012-3692</gtr:issn><gtr:outcomeId>58bd343dcb2256.23601859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>547AA882-E9D7-4E51-81ED-5135AB2744DA</gtr:id><gtr:title>A targeted metabolomics assay for cardiac metabolism and demonstration using a mouse model of dilated cardiomyopathy.</gtr:title><gtr:parentPublicationTitle>Metabolomics : Official journal of the Metabolomic Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/60c46c8b27756d4e59f65028a7eb54f2"><gtr:id>60c46c8b27756d4e59f65028a7eb54f2</gtr:id><gtr:otherNames>West JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1573-3882</gtr:issn><gtr:outcomeId>585d3305e204a7.97151705</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A34F1E3-6F6D-4FCE-BE99-FEF05B2B894F</gtr:id><gtr:title>Metabolomics dataset of PPAR-pan treated rat liver.</gtr:title><gtr:parentPublicationTitle>Data in brief</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/605afa4d43c7798be6ab908c49549eb0"><gtr:id>605afa4d43c7798be6ab908c49549eb0</gtr:id><gtr:otherNames>Ament Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2352-3409</gtr:issn><gtr:outcomeId>585d342e7f2a86.40199431</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F1E2AA4F-B743-473C-B65C-5D0533404286</gtr:id><gtr:title>Methods for performing lipidomics in white adipose tissue.</gtr:title><gtr:parentPublicationTitle>Methods in enzymology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/59b6e3728c2503ea027017abe00a44c7"><gtr:id>59b6e3728c2503ea027017abe00a44c7</gtr:id><gtr:otherNames>Roberts LD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:isbn>9780128002803</gtr:isbn><gtr:issn>0076-6879</gtr:issn><gtr:outcomeId>pm_53cc044c044e8b5c8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E66675EE-0814-4D3D-9EB0-C6137F23BC04</gtr:id><gtr:title>Regulation of mitochondrial morphology and function by stearoylation of TFR1.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/79ebcc3b3a811bc866b680f632d96c20"><gtr:id>79ebcc3b3a811bc866b680f632d96c20</gtr:id><gtr:otherNames>Senyilmaz D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>56bb67e64dba00.68005044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279D5D50-11B1-4C6A-B7F1-B2285F743BAA</gtr:id><gtr:title>Altered colonic mucosal availability of n-3 and n-6 polyunsaturated fatty acids in ulcerative colitis and the relationship to disease activity.</gtr:title><gtr:parentPublicationTitle>Journal of Crohn's &amp; colitis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2a9502c44a9b71d5a8aa8c96eba3aaa"><gtr:id>c2a9502c44a9b71d5a8aa8c96eba3aaa</gtr:id><gtr:otherNames>Pearl DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1873-9946</gtr:issn><gtr:outcomeId>5461fb52a6fe37.08289072</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A82C578B-6AC5-4CB9-9DD9-853BEAF1497B</gtr:id><gtr:title>Hyphenating size-exclusion chromatography with electrospray mass spectrometry; using on-line liquid-liquid extraction to study the lipid composition of lipoprotein particles.</gtr:title><gtr:parentPublicationTitle>Rapid communications in mass spectrometry : RCM</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/960462874c9da9ea24bdb5bdb2e6d469"><gtr:id>960462874c9da9ea24bdb5bdb2e6d469</gtr:id><gtr:otherNames>Osei M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0951-4198</gtr:issn><gtr:outcomeId>56bb67e5def017.50688243</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>184E99A8-0805-4E04-965E-3B049473E441</gtr:id><gtr:title>De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose.</gtr:title><gtr:parentPublicationTitle>Biological reviews of the Cambridge Philosophical Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40c65e61851af3447011ec6c3f3c98bd"><gtr:id>40c65e61851af3447011ec6c3f3c98bd</gtr:id><gtr:otherNames>Sanders FW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0006-3231</gtr:issn><gtr:outcomeId>56bb67e7d335c9.84354313</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB609F7F-A514-49C3-9254-E342414FC031</gtr:id><gtr:title>The use of stable isotopes in the study of human pathophysiology.</gtr:title><gtr:parentPublicationTitle>The international journal of biochemistry &amp; cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d27da3441cd4f99b4649723f2b52b490"><gtr:id>d27da3441cd4f99b4649723f2b52b490</gtr:id><gtr:otherNames>Charidemou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1357-2725</gtr:issn><gtr:outcomeId>5a9ebf63a04339.66378789</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C62C798-26E3-42CA-804F-F6F4F09618A7</gtr:id><gtr:title>Ethnic differences in beta-cell function, dietary intake and expression of the metabolic syndrome among UK adults of South Asian, black African-Caribbean and white-European origin at high risk of metabolic syndrome.</gtr:title><gtr:parentPublicationTitle>Diabetes &amp; vascular disease research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a233589cc0c6fc2373d8fcfde27a01de"><gtr:id>a233589cc0c6fc2373d8fcfde27a01de</gtr:id><gtr:otherNames>Goff LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1479-1641</gtr:issn><gtr:outcomeId>5461f69498d539.57141189</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F95FFBF-92F2-4E41-9566-D9B6E559C869</gtr:id><gtr:title>Comprehensive Metabolic Profiling of Age-Related Mitochondrial Dysfunction in the High-Fat-Fed ob/ob Mouse Heart.</gtr:title><gtr:parentPublicationTitle>Journal of proteome research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d33cf2ec743344310cadecc6294d895"><gtr:id>8d33cf2ec743344310cadecc6294d895</gtr:id><gtr:otherNames>Wang X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1535-3893</gtr:issn><gtr:outcomeId>56bb67e6b10902.17832355</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A41C1648-A2D3-438C-B595-2ECEE9B7D490</gtr:id><gtr:title>Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma.</gtr:title><gtr:parentPublicationTitle>Analytical chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/349eb91011e40528bfc06aa005b52db2"><gtr:id>349eb91011e40528bfc06aa005b52db2</gtr:id><gtr:otherNames>Siskos AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0003-2700</gtr:issn><gtr:outcomeId>58bd343d7e7072.19014368</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_13030</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>